• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SeqLL Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    1/18/24 4:30:53 PM ET
    $SQL
    Medical Specialities
    Health Care
    Get the next $SQL alert in real time by email
    false 0001605888 0001605888 2024-01-16 2024-01-16 0001605888 SEQL:CommonStockParValue.00001PerShareMember 2024-01-16 2024-01-16 0001605888 SEQL:WarrantsToPurchaseCommonStockMember 2024-01-16 2024-01-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported) January 16, 2024

     

    SEQLL INC.

    (Exact name of registrant as specified in charter)

      

    Delaware   001-40760   46-5319744
    (State or other Jurisdiction of
    Incorporation or Organization)
      (Commission File Number)   (IRS Employer
    Identification No.)

     

    3 Federal Street

    Billerica, MA

      01821
    (Address of Principal Executive Offices)   (zip code)

     

    (781) 460-6016

    (Registrant’s telephone number, including area code)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, par value $.00001 per share   SEQL   The Nasdaq Market LLC
    Warrants to purchase Common Stock   SQLLW   The Nasdaq Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

     

     

     

    Item 1.01 Entry Into a Material Definitive Agreement.

     

    Amendment No. 5 to the Merger Agreement

     

    As previously reported, on May 29, 2023, SeqLL, Inc., a Delaware corporation (the “Company”), SeqLL Merger LLC, a Delaware limited liability company and a wholly-owned subsidiary of the Company (“Purchaser Sub”), Atlantic Acquisition Corp, a Delaware corporation (“Atlantic”), Atlantic Merger LLC, a Delaware limited liability company and a majority-owned subsidiary of Atlantic (“Atlantic Merger Sub”), Lyneer Investments, LLC, a Delaware limited liability company (“Lyneer”), IDC Technologies, Inc., a California corporation (“IDC”), and Lyneer Management Holdings LLC, a Delaware limited liability company (“Lyneer Management”), entered into an Agreement and Plan of Reorganization, as amended on June 23, 2023, on October 5, 2023, October 17, 2023 and November 3, 2023 (the “Merger Agreement”), pursuant to which (i) Atlantic Merger Sub will be merged with and into Lyneer, with Lyneer continuing as the surviving entity (the “Lyneer Merger”), and (ii) Purchaser Sub will subsequently be merged with and into Lyneer, with Lyneer continuing as the surviving entity and as a wholly-owned subsidiary of the Company (the “SeqLL Merger” and, together with the Lyneer Merger, the “Mergers”).

     

    On January 16, 2024, the Company entered into Amendment No. 5 to the Agreement and Plan of Reorganization (the “Amendment”) with the other parties thereto. Prior to the Amendment, as consideration for the acquisition by the Company of Lyneer in the Mergers, the Company was to (i) with respect to the Lyneer Stock Consideration (as defined in the Merger Agreement), issue 90% of the Lyneer Stock Consideration to Prateek Gattani, the Chief Executive Officer and principal stockholder of IDC and the Chairman of the Board of the Company following the Mergers, and 10% of the Lyneer Stock Consideration to Lyneer Management, and (ii) with respect to the Cash Consideration (as defined in the Merger Agreement), pay $20,000,000 of the aggregate $35,000,000 of Cash Consideration to IDC and Lyneer Management in the form of convertible promissory notes in the aggregate principal amount of $20,000,000 (the “Merger Note”) and the balance in cash to IDC to be used by IDC to pay down indebtedness for which IDC and Lyneer are jointly and severally liable. The Amendment amends (i) the Lyneer Stock Consideration such that the 90% of the Lyneer Stock Consideration previously issuable to Prateek Gattani will now be issuable to IDC, and (ii) the Cash Consideration such that, of the $35 million of aggregate Cash Consideration, $12,750,000 will now be paid to IDC in order to repay at the closing of the Mergers outstanding indebtedness for which IDC and Lyneer are jointly and severally liable, and $3,500,000 will be paid to Lyneer Management, and (ii) the balance of the Cash Consideration will be paid at the closing by the issuance to IDC of a non-interest bearing convertible promissory note in the aggregate principal amount of $18,750,000 due on or before July 31, 2024, the proceeds of which shall be used by IDC to repay additional outstanding indebtedness for which IDC and Lyneer are jointly and severally liable. The Amendment has also extended the Termination Date (as defined in the Merger Agreement) to March 15, 2024.

     

    The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by the Amendment, a copy of which is filed as Exhibit 2.1 to this Current Report on Form 8-K. Unless otherwise defined herein, the capitalized terms used above are defined in the Merger Agreement.

     

    The foregoing summary of the Merger Agreement and the Amendment have been included to provide investors and securityholders with information regarding the terms of the Merger Agreement, as amended by the Amendment, and is qualified in its entirety by the terms and conditions of the Merger Agreement, as amended. It is not intended to provide any other factual information about the Company, Atlantic, Lyneer or their respective subsidiaries and affiliates. The representations, warranties and covenants contained in the Merger Agreement, as amended, were made only for purposes of such agreement and as of specified dates, were solely for the benefit of the respective parties to such agreement, may be subject to limitations agreed upon by the contracting parties, and may be subject to standards of materiality that differ from those applicable to investors. Moreover, certain representations and warranties in the Merger Agreement, as amended, may have been used for the purpose of allocating risk between the parties rather than establishing matters of fact. Accordingly, investors should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the Company, Atlantic, Lyneer, Lyneer Management or any of their respective subsidiaries or affiliates. Moreover, information concerning the subject matter of the representations, warranties and covenants may change after the date of the Merger Agreement, which subsequent information may or may not be fully reflected in the Company’s public disclosures.

     

     

     

    Item 7.01 Regulation FD Disclosure

     

    Forward-Looking Statements

     

    The information included herein and in any oral statements made in connection herewith include “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. All statements, other than statements of present or historical fact included herein, regarding the transactions described herein (the “Transactions”), the Company’s ability to consummate the Transactions and raise capital prior to the Mergers, the benefits of the Transactions, the Company’s future financial performance following the Transactions, as well as the Company’s and Atlantic’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects, plans and objectives of management are forward-looking statements. When used herein, including any oral statements made in connection herewith, the words “could,” “should,” “will,” “may,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project,” the negative of such terms and other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on the Company, Atlantic and Lyneer’s management’s current expectations and assumptions about future events and are based on currently available information as to the outcome and timing of future events. Except as otherwise required by applicable law, the Company disclaims any duty to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date hereof. The Company cautions you that these forward-looking statements are subject to risks and uncertainties, most of which are difficult to predict and many of which are beyond the control of the Company. These risks include, but are not limited to, general economic, financial, legal, political and business conditions and changes in domestic and foreign markets; the inability of the parties to successfully or timely consummate the Transactions or to satisfy the closing conditions, including the closing of the Capital Raise; the failure to realize the anticipated benefits of the Transactions, including as a result of a delay in its consummation; the occurrence of events that may give rise to a right of one or all of the Company, Atlantic and Lyneer to terminate the definitive agreements related to the Transactions; the risks related to the growth of the Company’s or Lyneer’s business and the timing of expected business milestones; and the effects of competition on the Company’s or Lyneer’s future business. Should one or more of the risks or uncertainties described herein and in any oral statements made in connection therewith occur, or should underlying assumptions prove incorrect, actual results and plans could differ materially from those expressed in any forward-looking statements. There may be additional risks that neither the Company, Atlantic or Lyneer presently know or that the Company, Atlantic and Lyneer currently believe are immaterial that could cause actual results to differ from those contained in the forward-looking statements. Additional information concerning these and other factors that may impact the Company’s expectations can be found in the Company’s periodic filings with the SEC, including the Company’s Annual Report on Form 10-K filed with the SEC on March 16, 2023 and any subsequently filed Quarterly Report on Form 10-Q and the Company’s Registration Statement on Form S-1 (Registration No. 333-272908), as amended, originally filed with the SEC on June 23, 2023. The Company’s SEC filings are available publicly on the SEC’s website at www.sec.gov.

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits

     

    See the Exhibit Index below, which is incorporated by reference herein.

     

    Exhibit No.   Description
    2.1*   Amendment No. 5 to Agreement and Plan of Reorganization dated as of January 16, 2024 among the Company, SeqLL Merger LLC, Atlantic Acquisition Corp, Atlantic Merger LLC, Lyneer Investments, LLC, IDC Technologies, Inc. and Lyneer Management Holdings LLC
         
    104   Cover Page Interactive Data File (the cover page XBRL tags are embedded in the inline XBRL document)

    * Schedules, exhibits and similar supporting attachments to this exhibit are omitted pursuant to Item 601(b)(2) of Regulation S-K. We agree to furnish a supplemental copy of any omitted schedule or similar attachment to the Securities and Exchange Commission upon request.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: January 18, 2024 SEQLL INC.
         
      By: /s/ Daniel Jones
        Daniel Jones
        Chief Executive Officer

     

     

     

     

      

    Get the next $SQL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SQL

    DatePrice TargetRatingAnalyst
    2/9/2022$3.00Buy
    Maxim Group
    More analyst ratings

    $SQL
    SEC Filings

    See more
    • SEC Form EFFECT filed by SeqLL Inc.

      EFFECT - SeqLL, Inc. (0001605888) (Filer)

      2/13/24 12:15:19 AM ET
      $SQL
      Medical Specialities
      Health Care
    • SEC Form S-1/A filed by SeqLL Inc. (Amendment)

      S-1/A - SeqLL, Inc. (0001605888) (Filer)

      2/12/24 3:01:45 PM ET
      $SQL
      Medical Specialities
      Health Care
    • SEC Form S-1/A filed by SeqLL Inc. (Amendment)

      S-1/A - SeqLL, Inc. (0001605888) (Filer)

      2/9/24 5:23:38 PM ET
      $SQL
      Medical Specialities
      Health Care

    $SQL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Atlantic International Corp. Acquires Lyneer Staffing Solutions

      ENGLEWOOD CLIFFS, N.J., June 21, 2024 (GLOBE NEWSWIRE) -- Atlantic International Corp. (OTC:ATLN) (OTC:SEQL) today announced the acquisition ("Acquisition") of Lyneer Staffing Solutions ("Lyneer"), a 28 year old national strategic staffing outsourced services and workforce solutions company servicing the commercial, professional, finance, direct placement, and managed service provider verticals. Lyneer has over 1,100 customers, including, among others, enterprise scale customers UPS, DHL, FedEx, XPO Logistics, Ryder, Ikea, PepsiCo, T-Mobile, Kraft Heinz, and Red Bull. The Company is using its best efforts to uplist in the near future onto a National Securities Exchange and remains optimist

      6/21/24 7:00:00 AM ET
      $SQL
      Medical Specialities
      Health Care
    • SeqLL Defers Proposed Cash and Stock Distributions to Stockholders in Connection With Proposed Acquisition

      BILLERICA, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ:SQL, SQLLW))), today announced the decision of its Board of Directors to cancel the special cash dividend and stock dividend that it intended to make to its common stockholders in connection with, and subject to, the consummation of its planned acquisition of Lyneer Investments LLC ("Lyneer") and the disposition of its current business operations. The Company had previously set September 26, 2023 as the record date for the dividends (the "Record Date"). While the Record Date had been set, the dividends had not yet been declared by the Board nor had the amount of the proposed dividends been set

      10/30/23 4:30:00 PM ET
      $SQL
      Medical Specialities
      Health Care
    • SeqLL Announces Cash and Stock Dividend Record Date

      BILLERICA, Mass., Sept. 15, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ:SQL, SQLLW))), announced today that its board of directors has set September 26, 2023 as the record date for its special stock dividend and cash dividend to be made to the holders of its common stock pursuant to the terms of the Agreement and Plan of Reorganization dated as of May 29, 2023, as amended (the "Merger Agreement"), by and among the Company, SeqLL Merger LLC, Atlantic Acquisition Corp., Atlantic Merger LLC, Lyneer Investments, LLC, IDC Technologies, Inc. and Lyneer Management Holdings LLC. The dividend distribution of shares of common stock of the Company and the cash dividend will

      9/15/23 5:24:58 PM ET
      $SQL
      Medical Specialities
      Health Care

    $SQL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Maxim Group initiated coverage on SeqLL with a new price target

      Maxim Group initiated coverage of SeqLL with a rating of Buy and set a new price target of $3.00

      2/9/22 8:40:22 AM ET
      $SQL
      Medical Specialities
      Health Care

    $SQL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Pfeffer David bought $20,163 worth of shares (20,000 units at $1.01), increasing direct ownership by 22% to 20,000 units (Amendment)

      4/A - SeqLL, Inc. (0001605888) (Issuer)

      1/30/23 11:37:35 AM ET
      $SQL
      Medical Specialities
      Health Care
    • SEC Form 4: Milos Patrice M. bought $10,088 worth of shares (10,000 units at $1.01), increasing direct ownership by 14% to 10,000 units (Amendment)

      4/A - SeqLL, Inc. (0001605888) (Issuer)

      1/30/23 11:37:03 AM ET
      $SQL
      Medical Specialities
      Health Care
    • SEC Form 4: Jones Daniel Robert bought $2,236 worth of shares (5,733 units at $0.39), increasing direct ownership by 0.24% to 2,392,365 units (Amendment)

      4/A - SeqLL, Inc. (0001605888) (Issuer)

      1/30/23 11:36:38 AM ET
      $SQL
      Medical Specialities
      Health Care

    $SQL
    Financials

    Live finance-specific insights

    See more
    • Atlantic International Corp. Acquires Lyneer Staffing Solutions

      ENGLEWOOD CLIFFS, N.J., June 21, 2024 (GLOBE NEWSWIRE) -- Atlantic International Corp. (OTC:ATLN) (OTC:SEQL) today announced the acquisition ("Acquisition") of Lyneer Staffing Solutions ("Lyneer"), a 28 year old national strategic staffing outsourced services and workforce solutions company servicing the commercial, professional, finance, direct placement, and managed service provider verticals. Lyneer has over 1,100 customers, including, among others, enterprise scale customers UPS, DHL, FedEx, XPO Logistics, Ryder, Ikea, PepsiCo, T-Mobile, Kraft Heinz, and Red Bull. The Company is using its best efforts to uplist in the near future onto a National Securities Exchange and remains optimist

      6/21/24 7:00:00 AM ET
      $SQL
      Medical Specialities
      Health Care
    • SeqLL Defers Proposed Cash and Stock Distributions to Stockholders in Connection With Proposed Acquisition

      BILLERICA, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ:SQL, SQLLW))), today announced the decision of its Board of Directors to cancel the special cash dividend and stock dividend that it intended to make to its common stockholders in connection with, and subject to, the consummation of its planned acquisition of Lyneer Investments LLC ("Lyneer") and the disposition of its current business operations. The Company had previously set September 26, 2023 as the record date for the dividends (the "Record Date"). While the Record Date had been set, the dividends had not yet been declared by the Board nor had the amount of the proposed dividends been set

      10/30/23 4:30:00 PM ET
      $SQL
      Medical Specialities
      Health Care
    • SeqLL Inc. Enters into a Definitive Merger Agreement with Lyneer Staffing Solutions and Atlantic Acquisition Corp.

      BILLERICA, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. ("SeqLL" or the "Company") (NASDAQ:SQL, SQLLW))), a technology company providing life sciences instrumentation and research services, today announced that it has entered into a definitive merger agreement (the "Merger Agreement") with Lyneer Investments, LLC ("Lyneer"), the indirect parent company of Lyneer Staffing Solutions, LLC and Atlantic Acquisition Corp. ("Atlantic"), and related parties, pursuant to which Lyneer will become a wholly-owned subsidiary of SeqLL. Under the terms of the Merger Agreement, SeqLL will pay $60,000,000 in cash to the Lyneer members, and issue to the Lyneer members and Atlantic, an aggregate o

      5/30/23 8:30:00 AM ET
      $SQL
      Medical Specialities
      Health Care